Breaking Down Shandong Xiantan Co., Ltd. Financial Health: Key Insights for Investors

Curious about whether Shandong Xiantan Co., Ltd. (002746.SZ) is weathering recent market shifts? This deep-dive dissects a 2024 revenue of 5.29 billion yuan (down 8.49% from 5.78 billion), a net income of 287.3 million yuan (down 8.75%), monthly sales swings-January 2025 chicken sales at 352 million yuan (‑22.39% YoY) versus March at 453.4 million yuan (+13.33% YoY), July at 511 million yuan (+18.19% YoY) and September at 484.93 million yuan (+11.95% YoY) driven by seasonality-and valuation and shareholder signals including an EPS (TTM) of 0.33 yuan, a P/E of 18.08 (forward P/E 17.03) and a final 2024 dividend yielding about 5.03% on a 5.13 billion yuan market cap; with limited debt, liquidity and cash-flow disclosures available, explore the following sections for granular revenue trends, profitability metrics, valuation nuance, risks like disease and feed-cost pressure, and potential growth avenues that investors should weigh carefully

Shandong Xiantan Co., Ltd. (002746.SZ) - Revenue Analysis

Shandong Xiantan Co., Ltd. reported full-year revenue of 5.29 billion yuan in 2024, down 8.49% from 5.78 billion yuan in 2023. Monthly and product-line performance through 2025 shows volatility driven by seasonality and production-day variations (e.g., Spring Festival in January 2025).

• 2024 total revenue: 5.29 billion yuan (-8.49% vs. 2023: 5.78 billion yuan)
• January 2025 chicken sales: 352.0 million yuan (-22.39% YoY)
• March 2025 chicken sales: 453.4 million yuan (+13.33% YoY)
• July 2025 sales: 511.0 million yuan (+18.19% YoY)
• September 2025 sales: 484.93 million yuan (+11.95% YoY)
• Primary seasonal influence: production-day reductions around Spring Festival contributing to January 2025 decline

Patterns suggest a recovery trajectory across 2025 after a weaker 2024, with month-to-month variability tied to seasonality and operational days. For broader strategic context and stated corporate direction, see Mission Statement, Vision, & Core Values (2026) of Shandong Xiantan Co., Ltd.

Shandong Xiantan Co., Ltd. (002746.SZ) Profitability Metrics

• Net income contraction (-8.75%) and EPS of 0.33 yuan signal near-term profitability pressure and variable revenue trends.
• P/E of 18.08 versus forward P/E 17.03 indicates modest market expectation of earnings recovery.
• Generous cash dividend (1.50 yuan/10 shares) and ~5.03% yield demonstrate a shareholder-return focus despite lower net profit.
• Dividend timing: final cash dividend payable on June 12, 2025 - relevant for income-oriented investors.

Shandong Xiantan Co., Ltd. (002746.SZ) - Debt vs. Equity Structure

• Market-cap signal: 5.13 billion yuan market value suggests meaningful equity backing versus peers of similar size.
• Disclosure gap: Absence of detailed debt figures prevents assessment of leverage, interest coverage, and refinancing risk.
• Investor implication: Without debt maturity profiles and covenant information, risk assessment relies on operating cash flow and external research.
• Actionable need: Investors should seek interim/annual reports or contact IR for total liabilities, short- vs. long-term debt split, and interest expense data.

Shandong Xiantan Co., Ltd. (002746.SZ) - Liquidity and Solvency

Available public sources do not provide the core data required to calculate standard liquidity and solvency ratios for Shandong Xiantan Co., Ltd. (002746.SZ). The following points summarize the current informational gaps and implications for investors.

• Current ratio: Not calculable - current assets and current liabilities not disclosed.
• Quick ratio (acid-test): Not calculable - inventory and other quick asset details unavailable.
• Debt-to-equity ratio: Not disclosed - total debt and shareholders' equity figures missing.
• Cash flow analysis: Cash flow statements are not provided, preventing assessment of operating cash generation and free cash flow.
• Short-term liquidity assessment: Cannot be performed without up-to-date balance sheet and cash positions.
• Long-term solvency assessment: Hindered by absence of leverage, interest coverage, and maturity profile data.

Investors seeking actionable insight into Shandong Xiantan Co., Ltd.'s liquidity and solvency should obtain the company's latest audited financial statements, interim balance sheets, and cash flow statements. For further company context and investor activity, see Exploring Shandong Xiantan Co., Ltd. Investor Profile: Who's Buying and Why?

Shandong Xiantan Co., Ltd. (002746.SZ) - Valuation Analysis

• P/E of 18.08 and forward P/E of 17.03 indicate the stock is priced at a moderate premium to earnings, implying modest expected earnings growth or a stable business profile priced by the market.
• Market cap of 5.13 billion CNY signals meaningful investor backing but places the company in a size category where liquidity and analyst coverage may be limited.
• A 5.03% dividend yield is attractive for income-focused investors, but sustainability depends on payout ratio and free cash flow trends (detailed cash-flow disclosures are currently limited).
• Absence of detailed earnings forecasts and growth projections prevents robust DCF or multi-scenario valuation modeling.
• Without peer-comparable metrics, relative valuation (EV/EBITDA, P/S, PEG) cannot be reliably assessed.

• Request or review historical payout ratios and latest cash-flow statements to assess dividend sustainability.
• Obtain management guidance, analyst estimates, or company forecasts to refine forward P/E context and derive growth assumptions.
• Seek comparable companies within the same sector and region to construct relative valuation multiples once data is available.
• Monitor announcements and filings for capital structure changes that could materially affect market cap and per-share metrics.

Shandong Xiantan Co., Ltd. (002746.SZ) - Risk Factors

• Seasonal sales swings: Spring Festival and other holidays can compress logistics and lower retail demand, producing quarter-to-quarter revenue variance often in the range of -10% to -30% for affected months.
• Disease outbreak risk: Avian influenza and similar epidemics can force culling and movement restrictions; mortality and forced disposal rates in severe outbreaks can exceed 10%-30% of bird inventories, translating into multi‑million‑CNY losses for mid‑sized integrators.
• Feed and input price exposure: Feed (corn/soybean meal) typically accounts for the majority of production cost. A 10% increase in feed prices can reduce gross margins by several percentage points (commonly 3-8 p.p.), depending on hedging and procurement strategies.
• Regulatory and compliance costs: Stricter food‑safety and environmental standards can require capital expenditures and ongoing compliance costs; one‑time retrofit CAPEX for waste‑management or effluent controls can range from tens to hundreds of millions CNY for modernization programs across multiple sites.
• Demand elasticity in downturns: Economic slowdowns reduce discretionary consumption-poultry volumes and ASPs may fall, with revenue declines of 5%-20% in mild-to-moderate domestic downturn scenarios.
• Concentration risk: Heavy reliance on the Chinese market exposes the company to domestic macro, policy and trade risks that can amplify the above factors.

• Quarterly revenue and margin seasonality patterns and YoY comparisons for holiday quarters.
• Disclosure of disease incidents, culling volumes, biosecurity investments and insurance recoveries.
• Feed procurement contracts, hedging disclosures and pass‑through mechanisms to customers.
• Capital expenditure plans and timing for environmental/food-safety retrofits, plus related permitting risks.
• Geographic and customer concentration metrics showing exposure to specific provinces or major retail chains.

Shandong Xiantan Co., Ltd. (002746.SZ) Growth Opportunities

Shandong Xiantan Co., Ltd. (002746.SZ) sits in a fragmented domestic poultry market where targeted initiatives can convert operational strengths into measurable growth. The following areas outline prioritized opportunities, estimated impacts, and tactical levers investors should watch.

• Geographic expansion: moving beyond core provinces to East and Central China urban centers could expand addressable revenue by an estimated 12%-18% over 3 years.
• Product diversification: introducing value-added chicken lines (ready-to-eat, marinated, chilled specialty cuts) can lift gross margins by 200-400 basis points versus commodity fresh-chicken sales.
• Technology & automation: targeted CAPEX in automated slaughtering, processing and packing (estimated investment RMB 100-200 million) could reduce direct labor and waste, delivering 3%-5% improvement in cost of goods sold (COGS) and raising adjusted EBITDA margins.
• Strategic partnerships & M&A: bolt-on acquisitions of regional processors or offtake agreements with retail chains can increase market share rapidly; a single regional acquisition with 5% market share could raise consolidated revenue by ~8% depending on purchase size.
• Health/organic segment growth: capturing premium-priced organic/antibiotic-free segments may allow price premiums of 15%-30% above conventional lines, improving product mix and top-line ASP (average selling price).
• Sustainability positioning: investments in low-emission farming and certified sustainable sourcing can unlock new retail contracts and command price premiums while potentially lowering long-term regulatory risk.

Scenario analysis - illustrative impact on key metrics over a 3-year horizon assuming staged execution:

Operational levers to realize the above:

• Optimize distribution: expand cold-chain logistics to reduce spoilage rates (current spoilage in industry peers often 1%-3% of production value; a 1 ppt reduction can add notable incremental revenue).
• SKU rationalization: prioritize SKU mix toward higher-margin ready-to-eat and chilled products.
• Digital sales & branding: boost direct-to-consumer and e-commerce channels to capture higher ASPs (digital channels often report 10%-30% higher margins for branded products).
• Supply-chain integration: secure upstream feed and breeder contracts to stabilize input cost volatility and protect margin.
• ESG & certifications: obtain organic/antibiotic-free certifications to access premium retail listings and export opportunities.

Key KPIs investors should monitor to track execution:

• Revenue by product line (fresh vs. value-added) and by geography - target >15% of revenue from value-added within 2-3 years.
• Gross margin and adjusted EBITDA margin trends - improvements of 200-500 bps provide validation.
• CAPEX run rate and ROIC on automation/plant upgrades - aim for payback within 3-5 years.
• Share of sales through cold-chain and e-commerce channels - rising share signals successful premiumization.
• Sustainability metrics (emissions per ton, certified supply %) - increasing certification should correlate with premium pricing and new contracts.

For strategic context and corporate intent that complements these opportunities, see company guiding materials: Mission Statement, Vision, & Core Values (2026) of Shandong Xiantan Co., Ltd.